Quick Answer
Valion Bio, Inc. reported Shares Outstanding of 2.53 million shares for fiscal year 2025.
Valion Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.53M | +353.5% |
| 2024 | 556,902 | +545.8% |
| 2023 | 86,241 | -10.9% |
| 2022 | 96,778 | -99.0% |
| 2021 | 9.72M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.66M | -73.4% | +72.2% |
| June 30, 2025 | 965,899 | -84.4% | +36.9% |
| March 31, 2025 | 705,641 | -52.1% | +26.7% |
| December 31, 2024 | 556,902 | -62.0% | -91.1% |
| September 30, 2024 | 6.24M | +325.9% | +1.0% |
| June 30, 2024 | 6.18M | -79.2% | +319.6% |
| March 31, 2024 | 1.47M | -95.0% | +0.5% |
| December 31, 2023 | 1.47M | +1414.9% | +0.0% |
- Valion Bio, Inc. showed an increase of +353.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Valion Bio, Inc.’s shares outstanding has declined by 74.0% (from 9.72 million shares to 2.53 million shares).
- The most recent figure is from Valion Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: